Johnson & Johnson JNJ Cash Flow

Johnson & johnson (JNJ)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Apr'18	Dec'17	Sep'17	Jun'17	Mar'17	Jan'17	Sep'16	Jun'16	Mar'16	Jan'16	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income (Loss) Attributable to Parent
17,166	15,119	14,151	16,332	14,679	15,297	1,542	1,372	1,245	1,300	15,827	16,335	16,505	16,540	15,941	15,027	15,546	-	14,715	16,106	15,916	16,323	17,321	15,554	15,061	13,831	12,879	12,526	10,101	10,514	8,165	8,738	10,106	9,672	11,396	11,611	12,284	13,334	13,598	13,526	13,285	12,266	0	0	0
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property and intangibles
6,995	7,009	6,928	6,932	6,944	6,929	7,063	7,043	6,476	5,642	4,828	4,025	3,775	3,754	3,732	3,753	3,742	-	3,704	3,714	3,777	3,895	4,006	4,043	4,081	4,104	4,038	4,067	3,929	3,666	3,473	3,251	3,176	3,158	3,084	3,026	2,960	2,939	2,914	2,864	2,832	2,774	0	0	0
Stock based compensation
982	977	973	970	968	978	1,026	1,020	1,001	962	932	921	902	878	901	879	875	-	823	826	798	792	790	745	732	728	731	716	683	662	652	651	642	621	624	648	609	614	603	592	626	628	0	0	0
Venezuela adjustments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	108	108	108	108	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Asset write-downs
194	1,096	1,051	2,220	2,171	1,258	1,712	552	758	795	405	366	238	283	444	800	706	-	518	249	373	410	751	842	707	739	331	832	2,200	2,131	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Contingent consideration reversal
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net gain on sale of assets/businesses
2,082	2,154	2,899	2,853	1,289	1,217	0	0	0	-	-	-	-	-	-	-	-	-	1,321	3,085	2,421	2,383	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred tax provision
-2,060	-2,476	-3,195	-1,425	-1,422	-1,016	2,866	2,193	2,477	2,406	-963	-528	-761	-341	-288	-439	-422	-	377	132	491	441	-86	-106	-477	-607	61	564	-231	-39	-311	-843	-275	-836	-1,137	-752	-608	356	-333	-477	-688	-436	0	0	0
Accounts receivable allowances and credit losses
5	-20	-43	-14	-14	-31	-45	-23	10	17	58	17	-23	-11	6	9	38	-	28	14	-24	-28	-153	-139	-145	-131	-26	-20	39	92	139	148	90	32	-39	-67	-82	12	49	52	114	58	0	0	0
Changes in assets and liabilities, net of effects from acquisitions and divestitures:
(Increase) / Decrease in accounts receivable
1,258	289	810	532	549	1,185	1,373	1,146	1,016	633	629	443	772	1,065	259	345	57	-	758	849	586	247	60	569	624	632	1,074	811	228	9	332	184	521	915	111	228	287	207	71	-123	162	-453	0	0	0
Increase in inventories
67	277	291	576	691	644	3	-511	-627	-581	34	227	427	249	138	355	363	-	741	1,052	884	1,120	921	680	846	622	207	-70	-160	1	521	713	712	715	786	728	455	196	-148	-346	434	-95	0	0	0
Decrease in accounts payable and accrued liabilities
3,370	4,060	5,493	3,556	3,804	3,951	3,117	3,877	3,069	2,725	2,215	502	698	656	338	1,171	666	-	750	-142	-253	1,194	405	1,941	2,276	1,821	2,137	1,154	2,640	2,768	1,813	1,836	289	493	1,472	1,295	544	20	-229	-329	-3	-507	0	0	0
Decrease / (Increase) in other current and non-current assets
295	1,054	-548	870	-144	275	760	137	894	411	23	-271	-396	-18	1,603	1,499	343	-	-1,356	-1,608	-32	-442	1,273	1,875	1,237	1,693	822	1,134	1,118	1,264	1,509	1,217	1,569	1,785	1,330	950	456	574	-934	-533	-82	-1,209	0	0	0
Decrease in other current and non-current liabilities
1,264	1,425	1,356	-1,733	-2,607	-1,844	8,140	8,491	9,303	8,979	-198	-109	-477	-1,133	-412	589	921	-	-361	57	353	-1,096	-193	125	62	298	-162	-1,363	-2,836	-2,555	1,516	2,078	3,391	4,413	1,338	1,068	502	87	235	678	860	31	0	0	0
NET CASH FLOWS FROM OPERATING ACTIVITIES
23,231	23,416	23,262	22,007	22,138	22,201	22,062	22,056	21,749	21,056	21,604	20,699	19,491	18,767	17,199	17,978	18,886	-	19,088	17,602	17,659	18,710	18,245	19,538	19,060	17,414	16,651	15,684	14,878	15,396	15,471	15,113	14,777	14,298	14,671	15,083	15,011	16,385	17,848	17,908	17,434	16,571	0	0	0
CASH FLOWS FROM INVESTING ACTIVITIES
Additions to property, plant and equipment
3,467	3,498	3,556	3,630	3,668	3,670	3,592	3,563	3,377	3,279	3,132	3,079	3,147	3,226	3,499	3,551	3,559	-	3,593	3,555	3,627	3,714	3,647	3,705	3,639	3,595	3,318	3,191	3,018	2,934	2,910	2,939	2,959	2,893	2,724	2,541	2,423	2,384	2,269	2,260	2,327	2,365	0	0	0
Proceeds from the disposal of assets/businesses, net
3,029	3,265	5,411	5,351	3,436	3,203	2,001	2,577	1,821	1,832	1,120	707	1,273	1,267	2,717	2,956	3,379	-	1,770	5,251	4,706	4,631	4,747	884	387	458	796	966	1,257	1,509	1,526	1,889	1,579	1,342	921	558	543	524	466	251	250	154	0	0	0
Acquisitions, net of cash acquired
5,056	5,800	5,565	6,024	2,501	900	1,451	1,350	30,430	35,200	35,105	37,851	9,356	4,509	4,771	1,451	726	-	2,071	2,362	2,362	2,129	307	661	667	835	882	336	4,654	4,486	4,751	5,072	748	2,797	2,469	2,447	2,546	1,269	1,402	2,050	1,951	2,470	0	0	0
Purchases of investments
5,254	3,920	4,155	6,192	5,808	5,626	4,510	1,877	2,151	6,153	12,071	21,666	28,438	33,950	39,739	37,526	43,728	-	37,895	38,374	36,648	34,913	31,124	27,706	20,799	18,923	18,180	16,792	14,587	13,434	13,275	18,273	31,244	29,882	30,553	25,913	13,578	15,788	14,797	13,250	11,846	10,040	0	0	0
Sales of investments
3,436	3,387	5,586	5,678	5,443	4,289	1,768	1,540	19,464	28,117	32,854	44,325	35,629	35,780	41,419	37,095	37,244	-	32,710	31,726	26,092	24,119	19,743	18,283	19,335	18,058	15,554	12,911	10,997	14,797	24,092	29,697	32,099	30,396	22,870	17,883	13,558	11,101	9,204	8,561	7,522	7,232	0	0	0
Proceeds from credit support agreements, net
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
117	-44	344	430	562	464	165	187	233	234	203	165	121	123	105	130	93	-	187	216	229	299	373	344	343	266	-2	-30	-36	-38	451	724	723	778	299	79	86	38	16	46	52	109	0	0	0
NET CASH USED BY INVESTING ACTIVITIES
-5,358	-6,194	-2,622	-5,246	-3,659	-3,167	-5,900	-2,811	-14,857	-14,868	-16,537	-17,729	-4,160	-4,761	-3,978	-2,607	-7,483	-	-9,266	-7,530	-12,068	-12,305	-10,961	-13,249	-5,726	-5,103	-6,028	-6,412	-9,969	-4,510	4,231	4,578	-1,996	-4,612	-12,254	-12,539	-4,532	-7,854	-8,814	-8,794	-8,404	-7,598	0	0	0
CASH FLOWS FROM FINANCING ACTIVITIES
Dividends to shareholders
10,026	9,917	9,828	9,744	9,637	9,494	9,339	9,178	9,025	8,943	8,857	8,788	8,723	8,621	8,523	8,414	8,296	-	8,057	7,948	7,847	7,768	7,674	7,569	7,447	7,286	7,114	6,935	6,755	6,614	6,479	6,354	6,241	6,156	6,082	6,008	5,934	5,804	5,676	5,543	5,404	5,327	0	0	0
Repurchase of common stock
6,251	6,746	10,128	8,971	6,630	5,868	2,875	2,715	4,460	6,358	7,568	9,460	9,932	8,979	8,850	6,947	5,481	-	6,137	8,252	8,548	7,124	4,869	5,504	4,312	3,538	3,050	0	12,852	12,919	13,772	14,515	2,157	2,525	2,957	2,946	2,849	2,797	2,470	1,787	1,679	2,130	0	0	0
Proceeds from short-term debt
36	39	188	68	67	80	-3,851	-1,739	176	869	4,722	2,628	735	111	458	1,510	1,922	-	3,341	1,219	2,174	1,863	270	1,397	1,214	1,411	1,432	2,432	2,196	3,268	6,119	8,661	7,632	9,729	13,194	10,504	10,803	7,874	7,477	7,358	6,923	9,484	0	0	0
Repayment of short-term debt
102	100	201	58	11	2,479	2,759	3,583	3,619	1,330	-973	-2,490	-1,960	2,017	4,040	5,386	5,023	-	484	546	185	1,267	1,694	1,189	1,968	1,397	1,811	2,669	5,089	6,175	6,936	9,786	10,246	11,200	11,219	9,161	6,266	6,565	8,169	9,058	8,777	6,791	0	0	0
Proceeds from long-term debt, net of issuance costs
-	-	-	-	-	5	4,533	4,531	4,530	8,992	4,518	4,517	9,033	12,004	12,023	12,023	7,507	-	2,084	2,088	2,085	2,098	3,573	3,614	3,617	3,607	80	45	49	45	15	72	4,464	4,470	0	0	0	-	-	-	-	9	0	0	0
Repayment of long-term debt
1,832	2,823	1,653	2,551	2,549	1,555	1,663	1,771	1,783	1,777	2,294	1,302	2,211	2,223	994	983	66	-	84	88	1,839	1,844	1,849	1,866	1,613	1,593	1,539	2,298	775	804	800	21	43	16	23	25	27	32	16	215	218	219	0	0	0
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net
1,192	954	1,049	1,250	977	949	688	505	726	1,062	931	979	1,081	1,189	1,567	1,428	931	-	687	1,001	1,541	1,543	1,784	1,855	2,112	2,649	3,174	3,414	2,963	2,720	2,117	1,677	1,941	1,246	1,487	1,557	1,164	1,226	1,267	1,194	1,102	882	0	0	0
Other
166	575	241	87	-276	-148	-392	-300	-38	-188	-25	-40	-40	-15	-22	-7	-7	-	-50	-50	-50	0	0	0	26	56	84	133	107	-83	-111	-160	-160	0	0	0	0	-	-	-	-	-	-	-	-
NET CASH USED BY FINANCING ACTIVITIES
-16,814	-18,015	-20,332	-19,916	-18,056	-18,510	-15,658	-14,250	-13,493	-7,673	-7,600	-8,976	-8,097	-8,551	-8,381	-6,776	-8,513	-	-8,700	-12,576	-12,669	-12,499	-10,459	-9,262	-8,371	-6,091	-8,744	-5,878	-20,156	-20,562	-19,847	-20,426	-4,810	-4,452	-1,090	-557	-1,983	-4,980	-6,508	-8,051	-8,046	-4,092	0	0	0
Effect of exchange rate changes on cash and cash equivalents
-263	-9	-115	-38	-328	-241	-169	-24	331	337	49	-36	-186	-215	-274	-594	-1,017	-	-1,301	-1,093	-656	-310	-211	-98	-96	-204	-161	-129	-165	45	14	-197	-60	-47	-48	274	117	-6	-44	-36	170	161	0	0	0
Decrease in cash and cash equivalents
796	-802	193	-3,193	95	283	335	4,971	-6,270	-1,148	-2,484	-6,042	7,048	5,240	4,566	8,001	1,873	-791	-179	-3,597	-7,734	-6,404	-3,386	-3,071	4,867	6,016	1,718	3,265	-15,412	-9,631	-131	-932	7,911	5,187	1,279	2,261	8,613	3,545	2,482	1,027	1,154	5,042	0	0	0
Acquisitions
Fair value of assets acquired
6,210	7,228	6,862	7,457	3,082	1,047	1,489	1,110	31,806	36,937	36,986	40,003	9,829	4,586	4,791	1,441	705	-	2,339	2,644	2,643	2,167	321	836	842	1,028	1,053	349	19,211	19,025	19,320	19,645	780	3,025	0	0	0	-	-	-	-	-	-	-	-
Fair value of liabilities assumed and noncontrolling interests
1,144	1,418	1,250	1,386	534	100	101	-177	1,439	1,800	1,881	2,152	473	77	20	-10	-21	-	268	282	281	38	14	175	175	193	171	13	1,222	1,204	1,234	1,238	32	228	0	0	0	-	-	-	-	-	-	-	-
Net cash paid for acquisitions
5,066	5,810	5,564	6,023	2,500	899	1,402	1,301	30,381	35,151	35,105	37,851	9,356	4,509	4,771	1,451	726	-	2,071	2,362	2,362	2,129	307	661	667	835	882	336	17,989	17,821	18,086	18,407	748	2,797	0	0	0	-	-	-	-	-	-	-	-
Auris Health
Contingent consideration reversal
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-